Here’s Why This Real Estate Disruptor Chose a SPAC to Go Public
This innovative company chose a non-traditional route to the public markets.
Motley Fool
At Less Than $50, Could Pfizer Reach $100 Before 2025?
The reason it’s a long shot might surprise you.
Why This Ultra-High-Growth Healthcare Stock Is a Buy
When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.
This Growth Stock Could Be 10 Times Larger in 10 Years
The math works if everything goes right.
Finish 2021 Strong With These 3 Investing Moves
It might be early September, but thinking and taking action now can save you a hassle later — after key, year-end windows slam…
This Growth Stock Has Market-Beating Potential
This company dominates a fast-growing industry.
Here’s Why Meta Materials Stock Soared 32.9% Last Month
Despite its recent pricing surge, the stock is still down roughly 31% since going public in June.
Why Sunrun Stock Dropped 16.5% in August
Some stocks in the residential solar sector aren’t following the strong business performances, giving investors an opportunity….
3 Offbeat Cannabis Stocks Investors Should Consider
These three out-of-the-way marijuana stocks could be an investor’s best bet.
